11.01.2016 – 07:13

LifeWatch AG

EQS-Adhoc: LifeWatch AG: Agreement with AliveCor, Inc.

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Agreement
LifeWatch AG: Agreement with AliveCor, Inc.

11.01.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.

--------------------------------------------------------------------------------
LifeWatch AG signs agreement with AliveCor, Inc.

Zug/Switzerland, January 11, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services to the digital health market, is pleased to announce the
signing of an agreement with AliveCor Inc. to utilize the AliveCor(R) Mobile ECG
technology in its cardiac monitoring business. We are working together to
integrate the AliveCor Mobile ECG into LifeWatch's cardiac monitoring product
offering.

Dr. Stephan Rietiker, CEO of LifeWatch, commented, "Digital health monitoring is
revolutionizing how people interact with healthcare delivery. The AliveCor
Mobile ECG will enable LifeWatch to broaden its cardiac event monitoring
services, whilst at the same time opening the door to post-event cardiac
monitoring via a patient's own mobile device. This will provide the patient with
greater control and convenience. At the same time, physicians will benefit from
a broader range of attractive, diagnostic options. AliveCor's technology
offering complements that of LifeWatch, and emphasizes our commitment to using
the most innovative technologies available."

"We are excited about expanding into the remote patient monitoring market, which
will allow us to have a bigger impact on people's lives and bring healthcare
into the 21st century," said Vic Gundotra, chief executive officer of AliveCor.
"Using the AliveCor Mobile ECG will keep patients in touch with their physicians
outside of the hospital and can help to identify cardiac problems before
something life-threatening occurs."

The AliveCor Mobile ECG records accurate ECGs and heart rate anywhere and at any
time. The customer simply rests the fingers on the device or places the device
to the chest to record an ECG in just 30 seconds. A first response is provided
immediately with an in-depth expert analysis available as required.

 

For further questions:

LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35 / +41 79 410 81 88
E-mail:  investor-relations@lifewatch.com


About LifeWatch AG:
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading
U.S.-based provider of cardiac monitoring services and home sleep testing of
Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is
a leading developer and manufacturer of telemedicine products. For additional
information, please visitwww.lifewatch.com.

About AliveCor, Inc.
AliveCor Inc., is recognized around the world for transforming cardiac care. The
FDA cleared AliveCor(R) Mobile ECG is the most clinically validated mobile ECG
monitor on the market. It is recommended by leading cardiologists and used by
people worldwide for accurate ECG recordings. Today, we offer a simple to use
mobile device and service providing instant analysis for detecting atrial
fibrillation (AFib) and normal ECG's. AliveCor is a privately-held company
headquartered in San Francisco, Calif. For more information, please
visitwww.alivecor.com.

AliveCor is a trademark of AliveCor, Inc., registered in the U.S. and other
countries.

Sign upfor customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/alert-service.aspx

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE
UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF
LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED
STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES
LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS
SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE
ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.

End of ad hoc announcement

+++++
Additional features:

Document:http://n.eqs.com/c/fncls.ssp?u=PDLASKEDNN
Document title: LifeWatch AG signs agreement with AliveCor, Inc.

--------------------------------------------------------------------------------
11.01.2016 News transmitted by EQS Schweiz AG. www.eqs.com - news archive:
http://switzerland.eqs.com/de/News

The issuer is responsible for the contents of the release.
--------------------------------------------------------------------------------

Language: English

Company:  LifeWatch AG

          Baarerstrasse 139

          6300  Zug

          Switzerland

Phone:    +41 41 728 67 78

Internet: www.lifewatch.com

ISIN:     CH0012815459

Valor:    811189

Listed:   Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt ; SIX


End of News EQS Group News Service
--------------------------------------------------------------------------------
428069  11.01.2016